The study defines cancer microbiome as the aggregate of microorganisms living in or on the human body along with their genomes that are influencing cancer manifestation and progression. Cancer microbiome sequencing has increasingly become an area of interest for the research community, which has the potential to revolutionize cancer care, largely due to studies that have significantly correlated the microbiome’s involvement in cancer manifestation. This study aims at deciphering the potential of the cancer microbiome sequencing and its larger role in bolstering the current era of precision medicine. As per BIS Research analysis, the global cancer microbiome sequencing market is projected to reach $1,216.2 Million by 2031 from $155.5 Million in 2020, at a CAGR of 20.01% during the forecast period of 2021-2031. Growth in this market is expected to be driven by the increasing emphasis on the microbiome’s potential in the field of cancer, global i...